I'm no financial expert, but for what its worth, my allocation is as follows
40% Euro
10 % Irish (rem ISEQ is now industrials &agribusiness)
30% US
10% UK
10% Japan
So only half is exposed to currency risk / half is outside stressed euro
I understand that QLs bond fund is in only a tiny number of bonds (Irish/ Finnish/ German), so that would concern me
42% alloc to biotech is unusual? Its high risk (high return) & also has a currency risk
Mix (by present value) has evolved this way with good growth in Biotech units and losses in the others.
Not an expert here by any means and thanks for inputs. I will investigate bonds closer now and give consideration to reduction in Biotech, Irish (investment, agribusiness) and final currency mix too
An allocation of 30% to bonds implies a defensive investor but an allocation of 42% to Biotech implies an aggressive investor. So perhaps you need initially to assess your investment objectives?
Biotech is not an asset class; it’s a tilt or flavour in foreign developed market equities. But you’ve no other exposure to foreign developed market equities at the asset class level (e.g. S&P; FTSE), so perhaps you should consider rebalancing some of your gains in Biotech to S&P/FTSE and (perhaps?) JP.
[Disclosure: Long some but not all QL funds mentioned in this post. Disclaimer: The above is comment / observation and is not a recommendation to follow any particular investment strategy or to buy / not buy any particular fund or stock.]